Previous Article | Next Article ![]()
Journal of Virology, June 2001, p. 5252-5262, Vol. 75, No. 11
Division of
Ophthalmology1 and Department of
Pathology and Microbiology,3 University of
Bristol, Bristol BS8 1TD, and Division of Virology, University
of Cambridge, Cambridge CB2 1QP,2 United Kingdom
Received 5 December 2000/Accepted 2 March 2001
The spread of herpes simplex virus type 1 (HSV-1) during primary
ocular infection and after reactivation of latent infection in the
trigeminal ganglion (TG) was examined in the mouse using a genetically
modified virus containing the lacZ reporter gene under the
control of the immediate-early 110 promoter. Whole tissue mounts of the
eye and lids, their sensory nerves, and TG with the attached dorsal
root entry zone (DRE) into the central nervous system (CNS) were
stained for The ability of neurotropic
herpesviruses, such as herpes simplex virus (HSV), to spread in nerves
in a retrograde or anterograde direction, has long been recognized
(reviewed in reference 8). Although the route used by the
virus during such spread was debated for some time, in particular the
role of Schwann cells, intra-axonal transport is now generally accepted
as the underlying mechanism.
Morphological evidence has suggested that Schwann cells are relatively
resistant to infection (4, 6); however, tracts of infected
Schwann cells in peripheral nerves associated with the site of primary
infection have been described in many experimental studies (reviewed in
reference 12). The precise circumstances underlying such
infection and the role, if any, of Schwann cells in the pathogenesis of
herpetic infection have received little attention. It is noteworthy,
however, that in recurrent cutaneous herpetic lesions in humans, there
was frequent histopathological evidence of HSV infection in the Schwann
cells of nerve twigs with inflammatory infiltrates in and around the
nerves (46).
It has been hypothesized (13) that during retrograde
transport in the axon the virus would be unable to leave the axon and infect the associated Schwann cells, since it would have lost its
envelope during entry into nerve endings in the peripheral tissue
(26). It was further suggested that once new enveloped particles have been made in the cell body of sensory neurons, these
particles could leave axons, particularly if nonmyelinated, and infect
Schwann cells at different points along the nerve tract (13). Obtaining experimental evidence for such events
would require studies at different times after infection and probably detailed examination of many serial sections. In a previous study, this
demanding requirement was partly overcome by using whole mounts of eye
tissue following inoculation of the cornea with HSV (7).
Although this method successfully demonstrated by immunocytochemistry
the existence of antigen-positive Schwann cells in long tracts of
nerves in the eye, the sample did not include the trigeminal ganglion
(TG) itself, and therefore early spread of infection along the nerve
tract could not be studied. Moreover, because of their large size, the
antibody molecules necessary for immunocytochemistry cannot easily
penetrate into thicker tissues such as the cornea, so that areas of
significant antigen staining may be missed (32). We now
describe the use of a genetically engineered virus in which a reporter
gene for the bacterial enzyme The production of Viruses.
Viruses were propagated and assayed on Vero
cells. HSV-1 strain SC16 110 lacZ was derived from HSV-1
strain SC16 (16) as described previously
(22). In brief, virus SC16 110 lacZ contains a
968-bp promoter fragment which extends from position Animal models.
Specific pathogen-free, 8-week-old female
NIH/OLA inbred mice were obtained from Harlan/Olac; they were
maintained as a breeding colony in the Department of Pathology and
Microbiology. For studies on primary infection, mice were anesthetized
with 100 mg of ketamine (Parke-Davies Veterinary, Pontypool, United
Kingdom) per kg of body weight and 10 mg of xylazine (Bayer plc, Bury
St. Edmonds, United Kingdom) per kg of body weight and inoculated by
scarification of the left cornea with a 26-gauge needle
(44) through a 5-µl drop of medium containing
105 PFU of HSV-1 strain SC16 110 lacZ or of
HSV-1 strain SC16. Control mice were inoculated in the same way with a
preparation of uninfected Vero cells (mock inoculum) made in the same
manner as the virus inoculum. For studies on reactivation of latent
infection, mice were treated as described above, except that 24 h
before infection, animals were inoculated intraperitoneally with human
serum (Chemicon International, Temecula, Calif.) containing antibodies
to HSV-1 (34). The serum was diluted in phosphate-buffered
saline (PBS) to give a 50% effective dose of 8,000. Passive
immunization is used to protect the eye from the severely damaging
effects of HSV-1 disease (35). At least 35 days after
inoculation of virus, mice were anesthetized and placed with the left
eye proptosed below a Hanovia lamp (emitting a peak of 4.02 mJ/cm2 s at 320 nm), and the left cornea and lids were
irradiated for 90 s.
Examination of eyes and isolation of virus from eyewashings.
Mice were anesthetized, and the cornea, iris, and lids were examined
for signs of disease using a slit lamp microscope. Eyewashings were
taken and put onto Vero cells for the isolation of virus (44). For studies on primary infection, clinical
examination and isolation of virus was done immediately before mice
were killed. For studies on reactivation of latent infection, these
procedures were performed immediately before UV irradiation and on each
of days 1 to 4 after such treatment.
Dissection of tissues for
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.11.5252-5262.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Tracking the Spread of a lacZ-Tagged
Herpes Simplex Virus Type 1 between the Eye and the Nervous System of
the Mouse: Comparison of Primary and Recurrent Infection
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
-galactosidase. Sixteen hours after inoculation of the
cornea by scarification, staining was found in the scarified epithelium
of the cornea and in the unscarified conjunctiva. By 24 h,
staining was also seen in a few TG neurons and by 96 h their
number had greatly increased and their distribution was more
widespread. Stained cells (identified as Schwann cells by their
staining for glial fibrillary acidic protein [GFAP] or S-100) in the
TG were first seen close to stained neurons at 40 h, and by
48 h lines of such cells extended partway toward the periphery and
toward the DRE. By 72 h, these lines had reached the periphery and
the DRE where the adjacent CNS was also stained. In the cornea, stained
cells with the morphology and arrangement of Schwann cells were seen
from 40 to 120 h. After reactivation of latent infection, 10 of 22 samples had positively stained neurons. In eight samples, corneal and
lid epithelial cells were stained. No stained Schwann cells were seen
in the TG; however, branched networks of such cells were present in the
cornea and the lids. This detailed sequential analysis has provided new
information on the involvement of Schwann cells in the pathogenesis of
primary and recurrent HSV-1 disease in the TG and the cornea.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
-galactosidase (
-Gal) has been
inserted into a nonessential gene of HSV-1, Us5, under the control of
the promoter of an HSV immediate-early gene, IE110 (22).
Both in tissue culture and in vivo, expression of
-Gal occurs during lytic infection and is switched off once latency is established. Moreover, in primary neuronal cultures infected with virus recombinants expressing reporter genes from the IE110 or human cytomegalovirus IE
promoters, the percentages of reporter gene-positive neurons were
similar to the proportions of cells expressing viral antigen (1). This suggests that the detection of the ICP0 reporter gene gives an accurate reflection of viral protein synthesis. However,
since the promoter activity would mark cells very early in the lytic
cycle (i.e., prior to virus production), we cannot be sure that some
cells are not abortively infected.
-Gal allows detection of virus-infected cells by
using reagents which more easily penetrate tissues than antibody.
Moreover, we have now developed a more extensive whole mount of tissues
which includes not only the eye but also its sensory nerve supply from
the TG, the ganglion itself, and the attached entry zone from the
ganglion into the brain stem (dorsal root entry [DRE]). The
combination of this comprehensive tissue preparation and the tagged
virus has therefore allowed us to perform a detailed sequential
analysis of the events in different parts of the nervous system and
ocular tissues at various times after primary infection and thereby to
clarify the involvement of Schwann cells. Moreover, since the tagged
virus establishes latency and reactivates in a manner similar to that
of the parental strain (22), we have been able to use our
model of recurrent ocular disease (34) to make a similar
analysis of events following UV-induced reactivation of latent virus in
the TG.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
818 to position
+150 with respect to the IE110 transcription start site linked to
lacZ and inserted into the nonessential Us5 locus of HSV-1
strain SC16. When grown in tissue culture, this virus produces blue
-Gal-positive plaques.
-Gal staining.
Anesthetized
mice were perfused with 2% paraformaldehyde containing 0.2%
glutaraldehyde. A block dissection was made of the left TG with its
following attachments: DRE, ophthalmic nerve (lacrimal, frontal, and
nasociliary branches), maxillary nerve, optic nerve, eyeball,
conjunctiva, and upper and lower eyelids. The TG consisted of its three
parts: ophthalmic (TG1), maxillary (TG2), and mandibular (TG3). To
facilitate penetration of the staining reagents into the eyeball, the
lens was removed via a limbal incision. A schematic of the block
dissection is shown in Fig.
1A.

View larger version (36K):
[in a new window]
FIG. 1.
Diagrammatic representation of
-Gal staining in
whole tissue mounts (ocular structures, their trigeminal nerve supply,
the trigeminal ganglion, and its root in the brain stem) at different
times after inoculation of the cornea with HSV-1 SC16 IE110
lacZ. (A) Key to diagram. In the mounted specimen, the part
containing the conjunctiva, lids, and skin (lower right in panel A)
remains attached to the ophthalmic nerve, but for clarity this is drawn
separately. Similarly, in the specimen, the iris (lower center in panel
A) is a part of the anterior segment but again, for clarity, this is
drawn separately. TG1, ophthalmic part of the trigeminal ganglion; TG2,
maxillary part; TG3, mandibular part; oph. n, ophthalmic nerve; max. n,
maxillary nerve; man. n, mandibular nerve; B.S, brainstem; d.r.e,
dorsal root entry zone; cor, cornea; ir, iris; p.m., pupillary margin;
sk, skin; l.m, lid margin; i.p. con, inferior palpebral conjunctiva;
s.p. con, superior palpebral conjunctiva. In panels B through F, the
colored areas indicate cells or regions with
-Gal staining: red,
individual neuronal cell bodies (where such cells were too numerous to
count, the region involved is represented as a larger red area); blue
dashed lines, Schwann cells; yellow, areas of staining in epithelial
tissues (cornea, conjunctiva, skin) and iris; blue-green, staining in
the CNS.
Histochemical detection of
-Gal.
-Galactosidase was
detected as described previously (21). In brief, tissues
were fixed for 1 h on ice in 2% paraformaldehyde containing 0.2%
glutaraldehyde. They were then washed twice in detergent solution
(0.01% sodium desoxycholate, 0.02% Nonidet P-40, 2 mM
MgCl2 in PBS) and left on ice in this solution for 30 min.
Tissues were then incubated at 37°C for 3 to 4 h in X-GAL solution (detergent solution containing 4.5 mM potassium ferricyanide, 4.5 mM potassium ferrocyanide and 1 mg of
5-bromo-4-chloro-3-indolyl-
-D-galactopyranoside [X-Gal] per ml), transferred to 20% glycerol in PBS for 1 h at 4°C, and then incubated overnight at this temperature in 50%
glycerol in PBS. While being viewed through an operating microscope,
the anterior segment (cornea, sclera, and iris), including a small amount of bulbar conjunctiva, was dissected away from the eye and
incisions were made in the eyelids to allow the tissues to be laid flat
on glass microscope slides. They were mounted in Apathy's medium, and
the coverslips were sealed with nail varnish.
-Gal expression. Tissues were
then rapidly dehydrated and embedded in paraffin wax. Serial sections
were cut and counterstained with neutral red. Examination of the
sections showed positive staining throughout the entire TG, confirming
the penetration of the staining reagents into the thickest part of the
tissue block.
EM.
To facilitate location of infected cells, tissue samples
were taken from mice 120 h after inoculation of the cornea with
HSV-1 SC16 110 lacZ (when numbers of infected Schwann cells
were at a maximum). The blue-stained tracts of cells in the ophthalmic nerve were dissected out and then fixed overnight in sodium cacodylate buffer containing 2.5% glutaraldehyde. However, tissues prepared in
this way had poor morphology when observed by electron microscopy (EM).
Further studies where the 2% paraformaldehyde containing 0.2%
glutaraldehyde fixative used in the
-Gal staining was replaced by a
fixative used for EM preparations, sodium cacodylate buffer containing
2.5% glutaraldehyde, failed to improve the morphology. However,
similar numbers of
-Gal-positive cells were seen after use of either
fixative, suggesting that the increase in concentration of
glutaraldehyde had not reduced the sensitivity. The best morphology was
found in samples from mice perfused with sodium cacodylate buffer
containing 2.5% glutaraldehyde followed by overnight incubation at
4°C in this fixative but unstained for
-Gal. In all cases, tissues
were finally postfixed in osmium and embedded in LR White. Ultrathin
sections, at several levels across the nerve, were stained with uranyl
acetate and lead citrate and examined by transmission EM.
Identification of Schwann cells using antibodies to GFAP or S-100
protein.
Antibodies to glial fibrillary acidic protein (GFAP) and
S-100 were chosen, since these mark glial cells, including Schwann cells. Block dissections from six mice infected on the cornea 120 h
previously with HSV-1 SC16 110 lacZ were prepared and
stained for
-Gal as described above. Two samples were postfixed
overnight in 2% paraformaldehyde containing 0.2% glutaraldehyde and
then dehydrated and embedded in paraffin wax. Serial 6-µm sections were cut. The remaining four samples were stained as whole mounts, and
to facilitate penetration of the antibodies into the corneal stroma, 10 radial full-thickness incisions were made into the corneas. These whole
mounts and the sections were stained by the avidin-biotinylated
horseradish peroxidase complex (ABC) method using the following
reagents in sequence: 3% hydrogen peroxide, 20% normal goat serum,
rabbit anti-GFAP serum (DAKO) diluted 1:500 or rabbit anti-S-100 serum
(Sigma) diluted 1:800, biotinylated goat anti-rabbit (Vector) diluted
1:50 and preabsorbed with normal mouse serum, ABC (Vector), and
diaminobenzidine (Vector). Samples were washed three times in PBS
between steps. Negative control samples were incubated with normal
rabbit serum at the same concentrations as the respective primary antibodies.
Examination of slides and measurement of areas of staining.
Whole mounts were examined using 4×, 10×, 20×, and 40× objectives.
Tissue sections were examined using 40× and 100× objectives. Areas of
-Gal staining in the corneal epithelium were measured using a
Quantimet 500 Image Analysis system (Leica, Cambridge Ltd., Cambridge,
United Kingdom). Normal probability plots showed that the data
conformed to a normal distribution and thus allowed comparisons by
analysis of variance. Multiple unplanned comparisons were made by the
method of Tukey (39); the level of significance was set at
5%.
| |
RESULTS |
|---|
|
|
|---|
Primary infection. (i) Experimental protocol.
Four mice
inoculated with HSV-1 strain SC16 110 lacZ and one given
mock inoculum were taken on each of the following hours after
inoculation: 16, 24, 40, 48, 72, 96, 120, and 168. In addition, one
mouse inoculated with the parental virus, HSV-1 strain SC16, was taken
at 120 h. Mice were examined for clinical disease and eyewashings
were taken for the isolation of virus, and then the animals were killed
and their tissues were removed and processed for
-Gal staining.
(ii) Eye disease and isolation of virus from eyewashings. Sixteen hours after inoculation of HSV-1 strain SC16 110 lacZ, all mice had multiple corneal epithelial ulcers, some punctate and some linear, and by 24 h these ulcers were larger and underlaid by haze. At 40 and 48 h, animals had large central corneal ulcers, iris hyperemia, and enlargement of the limbal vessels. By 96 h, corneas had more severe haze or opacity and animals had swollen lids which, by 120 h, had progressed to lid disease (ulcers and scabs). Eyewashings at all timepoints from 16 to 168 h yielded large amounts of virus (>100 PFU/eye).
(iii) Identification of types of infected cells.
In whole
mounts, infected (blue-staining) Schwann cells were identified by their
characteristic long thin shape and end-to-end arrangement, usually in
tracts, following the predicted course of nerves and more intense
staining around their nuclei. In tissue sections, cells in the
ophthalmic and maxillary nerve tracts after inoculation of the cornea
120 h previously with HSV-1 were confirmed to be Schwann cells by their
double staining for
-Gal and either GFAP (Fig.
2A1) or
S-100 and by the EM of ultrathin sections (see below). Attempts to
apply the double-staining method to identify corneal Schwann cells in
whole mounts were disappointing. No cells stained positively for GFAP
or S-100 were seen, most likely due to poor penetration of the
antibodies into this relatively thick tissue. We were therefore
unable to identify unequivocally the infected Schwann cells of
corneal nerves.
|
(iv) Identification of HSV-1-infected Schwann cells by EM.
In
the ophthalmic nerve taken from mice 120 h after inoculation of
the corneas with HSV-1 SC16 110 lacZ, nuclei with marginated chromatin and intranuclear herpes capsids were seen in several sections. Such cells were identified in the tissues from two mice processed for EM after
-Gal staining and in a further two after conventional fixation for EM. As expected, the tissue preservation was
much better in the latter. At one end of the nerve fragment, presumably
at the edge of the ganglion, a few neurons were seen, readily
identified by their characteristic morphology and the closely apposed
satellite cells. Some of these neurons showed the signs of herpetic
infection mentioned previously. All other herpes-infected cells (a
total of approximately three to four per section) had characteristics
of Schwann cells, viz., an elongated shape and a basement membrane
covering the plasma membrane (Fig. 3).
Moreover, all such cells were nonmyelinating Schwann cells with naked
axons in their cytoplasm and none showed evidence of virus capsid
envelopment.
|
(v) Assessment of
-Gal staining in tissues.
No
-Gal-positive staining was seen in samples from mock-inoculated mice
or in the sample taken from a mouse 120 h after infection with
HSV-1 strain SC16, the untagged parental virus, which lacks the
reporter gene. The incidence and distribution of
-Gal-positive staining in the tissues tested on successive timepoints after inoculation of HSV-1 strain SC16 110 lacZ are shown in Table
1. A diagrammatic representation of
staining in whole tissue mounts at different times after inoculation of
the cornea with HSV-1 SC16 110 lacZ is shown in Fig. 1B
through F. In samples from control and infected mice the level of
background staining was extremely low; however, some pale nonspecific
staining was seen in the meibomian glands of the eyelids (Fig. 2B2).
|
(vi) Staining in the corneal epithelium. Sixteen hours after infection, all mice had large numbers of intensely stained corneal epithelial cells (Table 1). The pattern of distribution of stained cells resembled the scarification lines made during the inoculation procedure, with the majority of staining in the central cornea (Fig. 2B1). At 24 h (Fig. 1B), the areas of staining in the corneal epithelium had increased to an average of 2.3 mm2, whereas the pattern and intensity of staining was similar to that seen at 16 h. By 40 h, the intensity of staining had declined and the area of staining in the corneal epithelium had decreased significantly (P < 0.05) to an average of 0.7 mm2. Moreover, the pattern of distribution of such staining had changed, with positive cells surrounding a large central unstained area which corresponded with the central corneal epithelial ulcer seen clinically. At 96 and 120 h, foci of intensely stained cells appeared, peripheral to the fading central ulcers (Fig. 1F). These account for the slight increases in the areas of stained corneal epithelial cells seen at these timepoints (an average of 0.9 mm2). Similar foci were still present at 168 h.
(vii) Staining in corneal nerves. Three of four samples taken at 40 h had staining in single or thin bundles of lines of cells morphologically resembling Schwann cells of corneal nerves (Table 1; Fig. 1C). Contiguous stained lines stretched through the bulbar conjunctiva and sclera into the cornea and these often branched at the limbus. At 48 and 72 h, all samples had such staining and the lines of cells had become more numerous and thicker, and their branches formed a network of stained Schwann cells in the cornea. These networks were particularly prominent in the periphery of corneas and lay below stained corneal epithelial cells as judged by the plain of focus. By 120 h, staining of these networks was scanty, and at 168 h no such staining was seen.
(viii) Staining in the iris.
-Gal-positive staining was
seen in the iris only in samples taken 96 and 120 h after inoculation
(Table 1). Stain was seen along the edge of the pupillary margin and
sometimes in patches in the main body of the iris (Fig. 2B8).
(ix) Staining in the conjunctiva.
All samples taken at 16 h had small foci of
-Gal-positive cells in the superior palpebral
fornix (Fig. 2B2). By 24 h, the amount of staining in this tissue
had increased and foci of positive cells were also detected in the
inferior palpebral fornix (Fig. 1B), and many of the foci had developed
central holes and resembled ulcers. The areas of positively stained
conjunctival cells increased dramatically by 48 h, and many of the
infected cells were in the conjunctiva that overlaid both tarsal
plates. Between 72 and 168 h, the amount of
-Gal staining in
the conjunctiva declined.
(x) Staining in the lids.
Infected cells in the lid margins
first appeared at 40 h after inoculation when two of four samples
had small numbers of foci (one to three) of
-Gal-positive staining
(Table 1). By 72 h, the lids of all samples had foci of positive cells,
many of which appeared to be closely associated with hair follicles.
The amount of staining in lid margins increased, and all samples tested
at 96 and 120 h had almost continuous staining around the entire lid margins (Fig. 1F). At 168 h, the amount of staining had decreased.
(xi) Staining in the TG and DRE.
No
-Gal-positive staining
was detected in the TG 16 h after inoculation (Table 1). By
24 h, all samples had positive staining in small numbers (3 to 20 per TG) of isolated neuronal cell bodies in TG1 (Fig. 1B and 2B3). By
40 h after inoculation, infection had progressed in all samples to
larger numbers of neuronal cell bodies (30 to 100 per TG) and some of
their associated satellite cells. Many of the stained neuronal cell
bodies and satellite cells were in small clusters and their
distribution was more extensive than that seen at 24 h with some
stained cells in the part of TG2 bordering TG1 (Fig. 1C and 2B4).
Single lines of
-Gal-positive stained Schwann cells extended from
positively stained neuronal bodies. In all samples, these lines
extended towards the periphery and into the ophthalmic nerve. In
contrast, the lines extending centrally were much shorter. This, and
other staining of this type in other sites, was identified as being
within Schwann cells by the criteria described previously. However, in
all cases it is impossible to tell whether or not such staining in
nerve tracts also included some contribution from
-Gal within the
axons. By 48 h, lines of stained Schwann cells extended to the
peripheral nervous system (PNS) side of the DRE and those in the
ophthalmic nerve consisted of bundles of stained Schwann cells (Fig.
1D). Far smaller numbers of TG2 Schwann cells stained for
-Gal;
however, such stained cells were seen in the peripheral part of the
maxillary nerve. These were first detected at 72 h after
inoculation and were still present at 168 h. Small areas of
positive staining were first detected in the CNS at the DRE at 72 h in three of four samples tested. At 120 and 168 h all samples
had larger areas of such staining (Table 1) and the majority of
staining was diffuse, with only small numbers of stained cells visible
(Fig. 2B7). At this time, the numbers of stained neurons in TG1 were
too large to count (Fig. 1E and 2B5), and large bundles of stained
Schwann cells were seen extending from these neurons along the length of the ophthalmic nerve and in the PNS side of the DRE up to the junction.
-Gal staining was first detected in neuronal cell bodies in TG3 in one of four samples taken 96 h after inoculation of virus (Fig. 1F). There was no evidence of Schwann cell staining in TG3
or in the small portion of mandibular nerve available for examination.
At 96 h, staining was also seen in large bundles of Schwann cells
forming three tracts within the ophthalmic nerve (Fig. 2B6). These
tracts could be traced from stained neuronal cell bodies in TG1 and TG2
to the eyelid margins and tarsal conjunctiva, where they were sometimes
seen to branch. These three tracts are likely to be the frontal,
nasociliary, and lacrimal branches of the ophthalmic nerve.
Occasionally, small branches from one of the tracts were seen entering
the eye near the optic nerve. By 168 h, the number of positive
neurons had declined to 12 to 50 per TG. The majority of these cells
were in TG1 and TG2 and were stained intensely, suggesting recent infection.
Reactivation of latent infection. (i) Experimental protocol.
Twenty-two latently infected mice and four mice given mock inoculum
were treated with UV irradiation as described above. Eyewashings were
taken for the isolation of virus before UV irradiation and on each of
days 1 to 4 afterwards. On each of these days, four to seven latently
infected mice and one control mouse were killed and their tissues were
removed and processed for
-Gal staining. Six latently infected
animals were killed before UV irradiation and treated similarly. Eyes
were examined for signs of disease prior to UV irradiation and on the
day they were killed.
(ii) Eye disease and isolation of virus from eyewashings.
Prior to UV irradiation, all eyes were normal. After treatment,
transient corneal epithelial ulceration developed and resolved by day
3. In latently infected mice, recurrent dendritic keratitis was seen in
one animal on day 3. Recurrent lid disease was seen in one mouse on day
3 and two on day 4. No virus was isolated from the tears of mice prior
to UV irradiation or on day 1 after irradiation. Two animals shed virus
on a single day, one on day 2 and one on day 3. One mouse shed virus on
day 2 and day 3 (Table 2).
|
(iii) Assessment of
-Gal staining in tissues.
No
-Gal-positive staining was seen in samples taken from
mock-inoculated UV-irradiated mice or from the six latently infected animals sampled before UV irradiation. The pattern of
-Gal-positive staining in tissues from latently infected mice tested on successive timepoints after UV irradiation is shown in Table 2. The level of
background staining was similar to that described previously.
(iv) Staining in the TG and DRE.
-Gal-positive staining was
seen only in neurons. Ten of the 22 TG taken after UV irradiation had
such staining. Nine of these had a single stained neuron and one sample
had two stained cells. Stained neurons were seen at all time points
after UV irradiation, with the maximum incidence on day 1 when four of
four samples had positive cells (Table 2). All stained neurons were
within TG1, with four located in the rows of neuronal cell bodies that lie at the medial edge of this ganglion, six were deeper in TG1, and
one was close to the border between TG1 and TG2. Of the 11
-Gal-positive neurons, 9 had intense uniform staining over the entire cell body and 2 had discrete punctate staining. One cell with
uniform staining also had staining in its axon. The path of this axon,
traced by differential focusing, left the cell body in a lateral
direction and then turned towards the periphery (Fig. 2C1).
(v) Staining in the cornea and the lids.
-Gal staining was
seen in epithelial cells and in branched networks of cells with the
morphology and arrangement of Schwann cells in the cornea (Fig. 2C2)
and the lids. The amount of positively stained corneal epithelial cells
varied from one cell in a sample taken on day 1 to foci of cells in
samples taken on later days. One eye from day 3 had dendritic ulcers
(see above). The pattern and position of the ulcers and
-Gal
staining in the corneal epithelium of this eye were the same (Fig.
2C3). Stained corneal nerves were identified as early as day 1 and were
seen in some samples at all timepoints tested. The extent of staining
of these nerves varied from a few Schwann cells to a network of cells
covering half the cornea (Fig. 2C2). Positive staining of nerves and
epithelial cells were seen in two corneal samples, one on day 1 and the
other on day 3 (Table 2).
-Gal staining in lid epithelium was first seen on day 3, when three
of seven samples were positive. Positive staining in this tissue was
focal and appeared to be associated with hair follicles (Fig. 2C4). The
number of foci varied from one to many involving the entire lid margin.
On some samples with lid disease, stained Schwann cells were seen in
close association with foci of
-Gal-positive lid epithelial cells.
| |
DISCUSSION |
|---|
|
|
|---|
In previous studies, SC16 110 lacZ and the parental virus SC16 showed similar patterns of infection in mice following cutaneous infection (22), and in the present studies, following primary infection in the cornea, the two viruses produced similar ocular diseases. Although the product of gene Us5 may be antiapoptotic (18), our results provide further evidence that lack of this product (the putative glycoprotein gJ) has no significant effect on host-virus interactions (22), at least in the mouse.
As expected, following inoculation of the cornea with SC16 110 lacZ, extensive
-Gal staining was seen as early as
16 h (the first time tested) in the scarified epithelium. Less
expected at this early time was the marked staining in the fornix of
the upper palpebral conjunctiva, an unscarified area. By 48 h,
this staining involved the entire palpebral conjunctiva of both lids. This strongly suggests that the conjunctiva, unlike the cornea, can be
infected by some strains of HSV without necessarily suffering damage to
its epithelium. This involvement of the conjunctiva may also explain
the observed ability of strain SC16, but not strain McKrae, to produce
ocular infection in mice without corneal scarification when used at
high doses (19).
As made manifest by
-Gal staining of neurons, virus first arrived in
the TG between 16 and 24 h after inoculation of the cornea. At this
time,
-Gal expression in the TG was limited to a small number of
neurons, all within TG1, the part supplying sensory nerves to the
inoculation site. At these early times, during the period the first
virus was being transported along the nerve from the cornea to the
ganglion, no
-Gal expression was seen in Schwann cells along the
nerve tract. This confirms the generally accepted view that such cells
play no part in transport of virus during this period and that axonal
flow is the likely route of virus spread.
The absence of Schwann cell staining at this time also supports the suggestion that these cells are unlikely to become infected during retrograde transport (13) since the intra-axonal virions will have lost their envelopes as a result of membrane fusion at the nerve endings (26). Schwann cell staining was also absent during the movement of virus in the opposite direction, along nerves to the eye from reactivated infection in TG neurons. In this case, however, the virus being transported is likely to be enveloped. Nevertheless, the chances of Schwann cells becoming infected may be low since only small amounts of virus appear to be produced as a result of reactivation (37) and the axon involved may be myelinated.
The nerve tract from the cornea to the middle of the ophthalmic
division of the TG is about 8 mm long, which means the rate of
retrograde axonal flow of virus in trigeminal nerves was approximately 0.4 mm/h. In previous studies of HSV and pseudorabies virus with different nerves (of the hind limb or pinna of the ear), the rate of
retrograde flow was estimated to be slightly faster, about 2 mm/h
(4, 9, 10, 20, 28). The rate of flow of virus in the
opposite direction, after reactivation in the TG, must be very similar,
since in some samples with
-Gal- positive neurons at 24 h after
UV irradiation staining in what were probably Schwann cells of corneal
nerves was also present.
The number of
-Gal-positive neurons in TG1 became uncountable by
72 h after inoculation. Eventually, such neurons also appeared, but in much smaller numbers, in the other divisions, first in the TG2
at 40 h and then in TG3 by 96 h. This spread of infection within the TG, perhaps involving the "back-door route", has been described and discussed previously (36, 42, 43). With
respect to the ganglion itself and the main nerve tracts from the
ganglion,
-Gal expression in cells morphologically resembling
Schwann cells was first seen at 40 h in close proximity to
-Gal-positive neurons in the ophthalmic division. Such staining
extended for a short distance, within the ganglion, along nerve tracts
from TG1 toward the periphery and toward the CNS. By 72 h, this
staining had extended in both directions, as far as the eye and the
junction of PNS and CNS. At 120 h, when the putatively infected
Schwann cells were highest in number and therefore easier to locate in
sections of tissue, these cells were unequivocally identified as
Schwann cells by their double staining with
-Gal and GFAP or S-100,
markers known to be present in such cells and other glia
(29). The timing (after neurons were infected) and pattern
(progressively away from infected neurons in the ganglion) of this
Schwann cell involvement support the hypothesis that these cells can
become infected following a productive replication cycle in the
neuronal cell body, the flow of virus out along axons, and then the
emergence of such virus into associated Schwann cells along the nerve
tract. It has been argued that this emergence of virus into Schwann
cells is more likely if the virus being transported is enveloped
(13). It should be noted, however, that the state of virus
during such anterograde flow is controversial (reviewed extensively in
reference 8). Studies of an in vitro ganglion culture
system with one strain of HSV-1 indicate that virus moving in an
anterograde direction lacks an envelope (31), and indeed,
in this system, viral glycoproteins seem to be transported separately
(17). However, and perhaps more significantly, several in
vivo studies with different strains of HSV and pseudorabies virus
clearly show enveloped particles in transport vesicles within axons of
nerves (3, 9, 14, 23). A suggested correlation between the
virulence of different virus strains and the state of the transported
virus, virulent in vesicles or avirulent as naked capsids
(8), has yet to be proven.
We have also suggested that the emergence of virus during axonal transport is much more likely to occur from nonmyelinated axons where the barrier of a myelin sheath is absent (13). The wrapping of more than one nonmyelinated axon by a single Schwann cell would also increase the chance of such cells becoming infected. This predilection for infection in nonmyelinating Schwann cells is supported by EM of the sciatic nerve in mice infected with either HSV (4, 6) or pseudorabies virus (9), another highly neurotropic herpesvirus, in the hind footpad. In the present study, these observations were confirmed by EM of the ophthalmic nerve 5 days after inoculation. Other observations also suggest the importance of peptidergic neurons (which characteristically have nonmyelinated axons) in the pathogenesis of HSV infection (11, 24, 27, 40). In common with previous EM studies of infection in Schwann cells (4, 6), our observations of the lack of any capsid envelopment confirms the suggestion that these cells, like satellite cells (15, 45), are relatively resistant to infection with HSV-1.
The other notable site of Schwann cell infection was in the cornea
itself. The ability to detect the pattern and presence of such staining
clearly illustrates the very significant advantage of the whole mount
of the ocular and neural tissues. In primary infection, stained Schwann
cells were seen in fine-branching lines, presumably covering the
branching nerve fibers in the plexus under the corneal epithelium, as
early as 40 h after inoculation. After reactivation of virus in TG
neurons, such Schwann cell staining was also seen but as early as
24 h after irradiation of the cornea. Two possible scenarios could
explain how corneal nerve Schwann cells could become infected: (i) by
spread of infection from the epithelium into the boundary between the
epithelium and the stroma, where the nerves are situated, or (ii) by
virus travelling down axons from infected neurons in the ganglion. With
respect to the corneal Schwann cell staining seen so early after
reactivation of virus in the TG, significant epithelial
-Gal
staining did not occur until after 24 h and therefore could not be
the source of virus infecting Schwann cells. Therefore, leaving aside
the possibility of any corneal latency (5), infection of
Schwann cells could only have occurred from virus which had travelled down the axons of neurons in which reactivation had occurred. In the
case of primary infection, the later involvement of corneal Schwann
cells and the extension, from the periphery, of tracts of infected
Schwann cells in mandibular nerves may be indicative of the first
scenario (infection by spread from the epithelium into subepithelial
nerves). Alternatively, in primary infection, as in reactivation,
Schwann cells in the cornea might become infected as a result of
anterograde flow of virus from productively infected ganglionic neurons
(2). The particular susceptibility of the corneal Schwann
cells to infection may, as discussed above, relate to the lack of a
myelin barrier, in this case in all the nerves under the corneal
epithelium (30, 47).
In the case of reactivated infection, it is noteworthy that the
striking dendritic pattern of Schwann cells expressing
-Gal in the
cornea occurs as early as 24 h after UV irradiation in some mice
and that this precedes the time at which the overlying and similar
pattern of dendritic infection occurs in the corneal epithelium. Hence,
this may provide further circumstantial evidence to support the view
that the dendritic corneal ulcer, so pathognomic of recurrent herpetic
infection in the eyes of humans and mice (34), may occur
as a result of an "imprinting" from a slightly earlier and
anatomically defined pattern of infection in nerves which lie under and
very close to the epithelium (25).
In contrast to a previous report using a different mouse strain and a
different route of inoculation (41), we found no neurons expressing
-Gal in latently infected unirradiated animals at least
35 days after infection with HSV-1 SC16 110 lacZ. However, in our study, passive immunization was used prior to inoculation of
virus, a treatment which curtails the spread and subsequent establishment of latency in the TG (35); this may also
influence the pattern of
-Gal expression during latency.
In our previous experiments of UV-induced reactivation in the TG
(34, 37, 38), we have used the McKrae strain of HSV-1. From these experiments and other reports using a different mouse model,
a different virus strain, and reactivation induced by hyperthermia (33), it is apparent that very few neurons (often only one
or two per ganglion) become positive for virus antigens after a
reactivating stimulus. Nevertheless, we have shown that such an event
is sufficient to produce significant virus shedding in the eye and
clinical ocular disease (34, 37, 38). The
characteristically small numbers of
-Gal-expressing neurons seen
after UV irradiation of the cornea suggest that the recombinant virus
is capable of reactivation in vivo as well as in vitro
(22) and that the incidence of reactivation events in the
latently infected TG is similar to that of wild-type viruses.
In conclusion, valuable information on the pathogenesis of HSV infection has been obtained for both primary and reactivated infection by using a combination of a virus carrying a readily detected reporter gene with a tissue mount in which all the major elements involved in the local infection, in the eye and nervous system, can be examined at one time. In particular, it has allowed a greater appreciation of the extent of Schwann cell involvement and the possible role of such involvement in corneal nerves in determining the morphology of the dendritic lesion so characteristic of recurrent epithelial disease of the cornea.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by the Medical Research Council, United Kingdom, the National Eye Research Centre, United Kingdom, and the Henry Smith's Charity, United Kingdom.
We are grateful to Jenny Baker, Department of Pathology and Microbiology, University of Bristol, for the electron microscopy and photography.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Division of Ophthalmology, School of Medical Sciences, University of Bristol, University Walk, Bristol BS8 1TD, United Kingdom. Phone: 44-117-9287627. Fax: 44-117-9287896. E-mail: C.Shimeld{at}bris.ac.uk.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Arthur, J. L.,
C. G. Scarpini,
V. Connor,
R. H. Lachmann,
A. M. Tolkovsky, and S. Efstathiou.
2001.
Herpes simplex virus type 1 promoter activity during latency establishment, maintenance, and reactivation in primary dorsal root neurons in vitro.
J. Virol.
75:3885-3895 |
| 2. |
Blyth, W. A.,
D. A. Harbour, and T. J. Hill.
1984.
Pathogenesis of zosteriform spread of herpes simplex virus in the mouse.
J. Gen. Virol.
65:1477-1486 |
| 3. | Card, J. P., L. Rinaman, R. B. Lynn, B. H. Lee, R. P. Meade, R. R. Miselis, and L. W. Enquist. 1993. Pseudorabies virus infection of the rat central nervous system: ultrastructural characterization of viral replication, transport, and pathogenesis. J. Neurosci. 13:2515-2539[Abstract]. |
| 4. |
Cook, M. L., and J. G. Stevens.
1973.
Pathogenesis of herpetic neuritis and ganglionitis in mice: evidence of intra-axonal transport of infection.
Infect. Immun.
7:272-288 |
| 5. | Cook, S. D., and J. M. Hill. 1991. Herpes simplex virus: molecular biology and the possibility of corneal latency. Surv. Ophthalmol. 36:140-148[CrossRef][Medline]. |
| 6. | Dillard, S. H., W. J. Cheatham, and H. L. Moses. 1972. Electron microscopy of zosteriform herpes simplex infection in the mouse. Lab. Investig. 26:391-402[Medline]. |
| 7. |
Dyson, H.,
C. Shimeld,
T. J. Hill,
W. A. Blyth, and D. L. Easty.
1987.
Spread of herpes simplex virus within ocular nerves of the mouse: demonstration of viral antigen in whole mounts of eye tissue.
J. Gen. Virol.
68:2989-2995 |
| 8. | Enquist, L. W., P. J. Husak, B. W. Banfield, and G. A. Smith. 1998. Infection and spread of alphaherpesviruses in the nervous system. Adv. Virus Res. 51:237-347[Medline]. |
| 9. |
Field, H. J., and T. J. Hill.
1974.
The pathogenesis of pseudorabies virus in mice following peripheral inoculation.
J. Gen. Virol.
23:145-157 |
| 10. |
Field, H. J., and T. J. Hill.
1975.
The pathogenesis of pseudorabies virus in mice: virus replication at the inoculation site and axonal uptake.
J. Gen. Virol.
26:145-147 |
| 11. | Herbort, C. P., S. S. Weissman, and D. G. Payan. 1989. Role of peptidergic neurons in ocular herpes simplex infection in mice. FASEB J. 3:2537-2541[Abstract]. |
| 12. | Hill, T. J. 1985. Herpes simplex virus latency, p. 175-240. In B. Roizman (ed.), The herpesviruses. Plenum Press, New York, N.Y. |
| 13. | Hill, T. J. 1987. Ocular pathogenicity of herpes simplex virus. Curr. Eye Res. 6:1-7. |
| 14. | Hill, T. J., H. J. Field, and A. P. C. Roome. 1972. Intra-axonal location of herpes simplex virus particles. J. Gen. Virol. 15:253-255. |
| 15. |
Hill, T. J., and H. J. Field.
1973.
The interaction of herpes simplex virus with cultures of peripheral nervous tissue: an electron microscopic study.
J. Gen. Virol.
21:123-133 |
| 16. |
Hill, T. J.,
H. J. Field, and W. A. Blyth.
1975.
Acute and recurrent infection with herpes simplex virus in the mouse: a model for studying latency and recurrent disease.
J. Gen. Virol.
28:341-353 |
| 17. |
Holland, D. J.,
M. Miranda-Saksena,
R. A. Boadle,
P. Armati, and A. L. Cunningham.
1999.
Anterograde transport of herpes simplex virus proteins in axons of peripheral human fetal neurons: an immunoelectron microscopy study.
J. Virol.
73:8503-8511 |
| 18. |
Jerome, K. R.,
R. Fox,
Z. Cheng,
A. Sears,
H.-Y. Lee, and L. Corey.
1999.
Herpes simplex virus inhibits apoptosis through the action of two genes, Us5 and Us3.
J. Virol.
73:8950-8957 |
| 19. |
Kaye, S. B.,
C. Shimeld,
E. Grinfeld,
N. J. Maitland,
T. J. Hill, and D. L. Easty.
1992.
Non-traumatic acquisition of herpes simplex virus through the eye.
Br. J. Ophthalmol.
76:412-418 |
| 20. | Kristensson, K., E. Lycke, and J. Sjöstrand. 1971. Spread of herpes simplex virus in peripheral nerves. Acta Neuropathol. 17:44-53[CrossRef][Medline]. |
| 21. | Lachmann, R. H., and S. Efstathiou. 1997. Utilization of the herpes simplex virus type 1 latency associated regulatory region to drive stable reporter gene expression in the nervous system. J. Virol. 71:3197-3207[Abstract]. |
| 22. | Lachmann, R. H., M. Sadarangani, H. R. Atkinson, and S. Efstathiou. 1999. An analysis of herpes simplex virus gene expression during latency establishment and reactivation. J. Gen. Virol. 80:1271-1282[Abstract]. |
| 23. | LaVail, J. H., K. S. Topp, P. A. Giblin, and J. A. Garner. 1997. Factors that contribute to the transneuronal spread of herpes simplex virus. J. Neurosci. Res. 49:485-496[CrossRef][Medline]. |
| 24. | Ljungdhal, A., K. Kristensson, J. M. Lundberg, E. Lycke, B. Svennerholm, and R. Ziegler. 1986. Herpes simplex virus infection in capsaicin-treated mice. J. Neurol. Sci. 72:223-230[CrossRef][Medline]. |
| 25. | Lohmann, A. M., L. J. Müller, E. Pels, P. G. H. Mulder, and L. Remeijer. 1999. Corneal epithelial nerves are the anatomic basis for the dendritic figure caused by herpes simplex virus. Investig. Ophthalmol. Vis. Sci. 40:S549. |
| 26. |
Lycke, E.,
K. Kristensson,
B. Svennerholm,
A. Vahlne, and R. Zeigler.
1984.
Uptake and transport of herpes simplex virus in neurites of rat dorsal root ganglia cells in culture.
J. Gen. Virol.
65:55-64 |
| 27. |
Margolis, T. M.,
C. R. Dawson, and J. H. LaVail.
1992.
Herpes simplex viral infection of the mouse trigeminal ganglion.
Investig. Ophthalmol. Vis. Sci.
33:259-267 |
| 28. |
McCracken, R. M.,
J. B. McFerran, and C. Dow.
1973.
The neural spread of pseudorabies virus in calves.
J. Gen. Virol.
20:17-28 |
| 29. | Mirsky, R., and K. R. Jessen. 1986. The biology of non-myelin-forming Schwann cells. Ann. N. Y. Acad. Sci. 486:132-146[CrossRef][Medline]. |
| 30. |
Müller, L. J.,
L. Pels, and G. F. J. M. Vrensen.
1996.
Ultrastructure of human corneal nerves.
Investig. Ophthalmol. Vis. Sci.
37:476-488 |
| 31. |
Penfold, M. E. T.,
P. Armati, and A. L. Cunningham.
1994.
Axonal transport of herpes simplex virions to epidermal cells: evidence for a specialized mode of virus transport and assembly.
Proc. Natl. Acad. Sci. USA
91:6529-6533 |
| 32. |
Sanna, P. P.,
T. J. Deerinck, and M. H. Ellisman.
1999.
Localization of a passively transferred human recombinant monoclonal antibody to herpes simplex virus glycoprotein D to infected nerve fibers and sensory neurons in vivo.
J. Virol.
73:8817-8823 |
| 33. |
Sawtell, N. M., and R. L. Thompson.
1992.
Rapid in vivo reactivation of herpes simplex virus in latently infected murine ganglionic neurons after transient hypothermia.
J. Virol.
66:2150-2156 |
| 34. | Shimeld, C., T. Hill, B. Blyth, and D. Easty. 1989. An improved model of recurrent herpetic eye disease in mice. Curr. Eye Res. 8:1193-1205[Medline]. |
| 35. |
Shimeld, C.,
T. J. Hill,
W. A. Blyth, and D. L. Easty.
1990.
Passive immunization protects the mouse eye from damage after herpes simplex virus infection by limiting spread of virus in the nervous system.
J. Gen. Virol.
71:681-687 |
| 36. | Shimeld, C., J. L. Whiteland, S. M. Nicholls, E. Grinfeld, D. L. Easty, H. Gao, and T. J. Hill. 1995. Immune cell infiltration and persistence in the mouse trigeminal ganglion after infection of the cornea with herpes simplex virus type 1. J. Neuroimmunol. 61:7-16[CrossRef][Medline]. |
| 37. |
Shimeld, C.,
J. L. Whiteland,
S. M. Nicholls,
D. L. Easty, and T. J. Hill.
1996.
Immune cell infiltration in corneas of mice with recurrent herpes simplex virus disease.
J. Gen. Virol.
77:977-985 |
| 38. |
Shimeld, C.,
D. L. Easty, and T. J. Hill.
1999.
Reactivation of herpes simplex virus type 1 in the mouse trigeminal ganglion: an in vivo study of virus antigen and cytokines.
J. Virol.
73:1767-1773 |
| 39. | Snedecor, G. W., and W. G. Cochran. 1967. Statistical methods, 6th ed. Iowa State University Press, Ames, Iowa. |
| 40. | Stanberry, L. R. 1990. Capsaicin interferes with the centrifugal spread of virus in primary and recurrent genital herpes simplex virus infections. J. Infect. Dis. 162:29-34[Medline]. |
| 41. |
Thackray, A. M., and H. J. Field.
2000.
The effects of antiviral therapy on the distribution of herpes simplex virus type 1 to ganglionic neurons and its consequences during, immediately following and several months after treatment.
J. Gen. Virol.
81:2385-2396 |
| 42. |
Tullo, A. B.,
C. Shimeld,
W. A. Blyth,
T. J. Hill, and D. L. Easty.
1982.
Spread of virus and distribution of latent infection following ocular herpes simplex in the non-immune and immune mouse.
J. Gen. Virol.
63:95-101 |
| 43. | Tullo, A. B., D. L. Easty, T. J. Hill, and W. A. Blyth. 1982. Ocular herpes simplex and the establishment of latent infection. Trans. Ophthalmol. Soc. UK 102:15-18. |
| 44. | Tullo, A. B., C. Shimeld, W. A. Blyth, T. J. Hill, and D. L. Easty. 1983. Ocular infection with herpes simplex virus in nonimmune and immune mice. Arch. Ophthalmol. 101:961-964[Abstract]. |
| 45. | Wilkinson, R., C. Leaver, A. Simmons, and R. A. Pereira. 1999. Restricted replication of herpes simplex virus in satellite glial cell cultures clonally derived from adult mice. J. Neurovirol. 5:384-391[Medline]. |
| 46. | Worrell, J. T., and C. J. Cockerell. 1997. Histopathology of peripheral nerves in cutaneous herpesvirus infection. Am. J. Dermatol. 19:133-137. |
| 47. | Zander, E., and G. Weddell. 1951. Observations on the innervation of the cornea. J. Anat. 85:68-99[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||